Acute leukaemia, Acute myeloid leukaemia (AML), Blood cancers, Leukaemia, Myelodysplastic syndrome (MDS)
Results
Phase 1
This trial looked at the drugs azacitidine and lenalidomide for acute myeloid leukaemia or myelodysplasia that had come back after a stem cell transplant.
It was for people who had a stem cell transplant using cells from somebody else.
This trial was open for people to join between 2014 and 2016. The results were published in 2018.
Recruitment start: 5 February 2014
Recruitment end: 31 December 2016
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Charles Craddock
Bloodwise
Cancer Research UK Clinical Trials Unit, Birmingham
Celgene
Experimental Cancer Medicines Centres (ECMC)
NIHR Clinical Research Network: Cancer
University of Birmingham
TAP Network
Last reviewed: 9 March 2020
CRUK internal database number: 11009
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
